QHSLab, Inc. – OTC:USAQ

QHSLab stock price today

$0.189
-0.07
-27.31%
Financial Health
0
1
2
3
4
5
6
7
8
9

QHSLab stock price monthly change

+4.00%
month

QHSLab stock price quarterly change

+4.00%
quarter

QHSLab stock price yearly change

+188.89%
year

QHSLab key metrics

Market Cap
1.31M
Enterprise value
1.97M
P/E
-1
EV/Sales
1.01
EV/EBITDA
-3.32
Price/Sales
0.50
Price/Book
12.98
PEG ratio
0.1
EPS
-0.03
Revenue
1.54M
EBITDA
43.05K
Income
-294.33K
Revenue Q/Q
38.48%
Revenue Y/Y
24.51%
Profit margin
-75.19%
Oper. margin
-39.6%
Gross margin
50.19%
EBIT margin
-39.6%
EBITDA margin
2.79%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

QHSLab stock price history

QHSLab stock forecast

QHSLab financial statements

QHSLab, Inc. (OTC:USAQ): Profit margin
Jun 2023 404.76K -106.72K -26.37%
Sep 2023 336.40K -82.44K -24.51%
Dec 2023 315.02K -86.63K -27.5%
Mar 2024 488.58K -18.52K -3.79%
QHSLab, Inc. (OTC:USAQ): Analyst Estimates
2027 3.47M 3.57M 103.01%
  • Analysts Price target

  • Financials & Ratios estimates

QHSLab, Inc. (OTC:USAQ): Earnings per share (EPS)
2023-05-15 -0.02 -0.02
QHSLab, Inc. (OTC:USAQ): Debt to assets
Jun 2023 1848302 2.06M 111.74%
Sep 2023 1738933 2.03M 117.22%
Dec 2023 1681432 2.05M 122.34%
Mar 2024 1731151 2.11M 122.07%
QHSLab, Inc. (OTC:USAQ): Cash Flow
Jun 2023 -39.23K 0 55.00K
Sep 2023 13.06K 0 -71.67K
Dec 2023 -135.16K 0 136.50K
Mar 2024 56.57K 0 -41.22K

QHSLab alternative data

QHSLab, Inc. (OTC:USAQ): Employee count
Aug 2023 4
Sep 2023 4
Oct 2023 4
Nov 2023 4
Dec 2023 4
Jan 2024 4
Feb 2024 4
Mar 2024 4
Apr 2024 4
May 2024 4
Jun 2024 4
Jul 2024 4

QHSLab other data

  • What's the price of QHSLab stock today?

    One share of QHSLab stock can currently be purchased for approximately $0.19.

  • When is QHSLab's next earnings date?

    Unfortunately, QHSLab's (USAQ) next earnings date is currently unknown.

  • Does QHSLab pay dividends?

    No, QHSLab does not pay dividends.

  • How much money does QHSLab make?

    QHSLab has a market capitalization of 1.31M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 13.34% to 1.41M US dollars. QHSLab made a loss 468.36K US dollars in net income (profit) last year or -$0.02 on an earnings per share basis.

  • What is QHSLab's stock symbol?

    QHSLab, Inc. is traded on the OTC under the ticker symbol "USAQ".

  • What is QHSLab's primary industry?

    Company operates in the Healthcare sector and Medical Devices industry.

  • How do i buy shares of QHSLab?

    Shares of QHSLab can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does QHSLab have?

    As Jul 2024, QHSLab employs 4 workers.

  • When QHSLab went public?

    QHSLab, Inc. is publicly traded company for more then 6 years since IPO on 30 Nov 2018.

  • What is QHSLab's official website?

    The official website for QHSLab is usaqcorp.com.

  • Where are QHSLab's headquarters?

    QHSLab is headquartered at 901 Northpoint Parkway, West Palm Beach, FL.

  • How can i contact QHSLab?

    QHSLab's mailing address is 901 Northpoint Parkway, West Palm Beach, FL and company can be reached via phone at +92 93796503.

QHSLab company profile:

QHSLab, Inc.

usaqcorp.com
Exchange:

OTC

Full time employees:

5

Industry:

Medical Devices

Sector:

Healthcare

QHSLab, Inc., a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It also develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. In addition, the company provides quality health score lab expert system (QHSLab), a cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and store patient information electronically in a secure database; and distributes AllergiEnd, a diagnostic related product and allergen immunotherapy treatments to primary care physicians. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. QHSLab, Inc. has a strategic alliance with Medical License Factory, LLC. The company was incorporated in 1983 and is based in West Palm Beach, Florida.

901 Northpoint Parkway
West Palm Beach, FL 33407

CIK: 0000856984
ISIN: US90350R1077
CUSIP: 90350R107